Ophthalmology · San Antonio, TX
NPI
1336131499
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
303 E Quincy St, Suite 100
San Antonio, TX, 78215
Phone (210) 271-7648
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
15,300 services
Medicare patients, 2024
501
Average age 75
Drug cost, 2024
$4.1M
1,548 prescriptions
Company payments, 2025
$682
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles D Brodrick was code J2777 (injection, faricimab-svoa, 0.1 mg), 5,760 times for 16 patients. In total Charles D Brodrick billed 15,300 services in 35 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 5,760 | 16 | $27.37 | $158K |
| J2782 Injection, avacincaptad pegol, 0.1 mg | Office | 4,060 | 28 | $86.59 | $352K |
| 67028 Intravitreal Injection | Office | 1,049 | 124 | $85.00 | $89K |
| J0178 Injection, aflibercept, 1 mg | Office | 914 | 69 | $660.07 | $603K |
| 92134 Computerized Ophthalmic Imaging | Office | 866 | 404 | $30.15 | $26K |
| 92014 Ophthalmological E&M | Office | 828 | 426 | $87.27 | $72K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 792 | 26 | $263.99 | $209K |
| 92250 Angiography | Office | 278 | 161 | $26.60 | $7,396 |
| 92235 Angiography | Office | 244 | 134 | $123.97 | $30K |
| 92201 Ophthalmological E&M | Office | 94 | 94 | $18.37 | $1,727 |
| 99204 Office E&M - New | Office | 92 | 92 | $114.11 | $10K |
| J7999 Compounded drug, not otherwise classified | Office | 80 | 17 | $64.00 | $5,120 |
| J3490 Unclassified drugs | Office | 57 | 25 | $1,839.05 | $105K |
| 76512 Ultrasound - Nonspecific | Office | 25 | 19 | $38.29 | $957 |
| 99205 Office E&M - New | Office | 13 | 13 | $179.13 | $2,329 |
By year: 2022 $1.0M for 4,585 services; 2023 $1.1M for 5,574 services; 2024 $1.7M for 15,300 services.
Medicare prescription drug claims, 2024
In 2024, the drug Charles D Brodrick prescribed most often to Medicare patients was Eylea (Aflibercept), with 709 prescriptions and refills. In total Charles D Brodrick wrote 1,548 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eylea Aflibercept | 709 | 720 | 138 | $2.0M |
| Izervay Avacincaptad Pegol Sodium/Pf | 257 | 257 | 42 | $819K |
| Vabysmo Faricimab-Svoa | 183 | 186 | 50 | $655K |
| Eylea Hd Aflibercept | 138 | 252 | 51 | $573K |
| Ketorolac Tromethamine Generic | 85 | 85 | 25 | $2,186 |
| Combigan Brimonidine Tartrate/Timolol | 28 | 29 | Under 11 | $5,678 |
| Prednisolone Acetate Generic | 28 | 29 | 11 | $1,005 |
| Latanoprost Generic | 20 | 50 | Under 11 | $141 |
| Timolol Maleate Generic | 19 | 24 | Under 11 | $140 |
| Dorzolamide Hcl Generic | 14 | 24 | Under 11 | $247 |
| Prolensa Bromfenac Sodium | 12 | 17 | Under 11 | $4,246 |
Brand drugs: 1,381 claims; generic drugs: 167 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles D Brodrick $682 ($682 in general payments such as food, travel and fees) from 7 companies. The largest payer was Alcon Vision LLC with $272.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.